Hodgkin's disease in 35 patients with HIV infection: An experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF

Annals of Oncology

Volumn 10, Issue 2, 1999, Pages 189-195

  Errante, D ^a   Gabarre, J ^b   Ridolfo, A L ^f   Rossi, G ^c   Nosari, A M ^d   Gisselbrecht, C ^f   Kerneis, Y ^e   Mazzetti, F ^f   Vaccher, E ^a   Talamini, R ^f   Carbone, A ^a   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SPEDALI CIVILI   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e CENTRE HOSPITALIER RENÉ DUBOS   (France)

^f Centro di Riferimento Oncologico ^*

Author keywords

Antiretroviral; Chemotherapy; Granulocyte colony stimulating factor; HIV infection; Hodgkin's disease; Therapy

Indexed keywords

2',3' DIDEOXYADENOSINE; ANTIRETROVIRUS AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032997242     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008338915945     Document Type: Article

References (28)

1. Hessol NA, Katz MH, Liu JY et al. Increased incidence of Hodgkin's disease in homosexual men with HIV infection. Ann Intern Med 1992; 117: 309-11.
2. Biggar RJ, Burnett W, Mikl J, Nasca P. Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 1989; 43: 979-85.
3. Reynolds P, Saunders LD, Layefsky ME, Lemp GF. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980 1987. Am J Epidemiol 1993; 137: 19-30.
4. Lyter DW, Bryant J, Thackeray R et al. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1995; 13: 2540-6.
5. Serraino D, Pezzotti P, Dorrucci M et al. for the HIV Italian Seroconversion Study Group. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. Cancer 1997; 79: 1004-8.
6. Tirelli U, Errante D, Dolcetti R et al. Hodgkin's disease and human immmunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995; 13: 1758-67.
7. Rubio R. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cancer 1994; 73: 2400-7.
8. Andrieu JM, Roithmann S, Tourani JM et al. Hodgkin's disease during HIV-1 infection: The French registry experience. Ann Oncol 1993; 4: 635-41.
9. Lowenthal DA, Straus DJ, Campbell SW et al. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988; 61: 2325-37.
10. Knowles DM, Chamulak GA, Subar M et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108: 744-53.
11. Ames ED, Conjalka MS, Goldberg AF et al. Hodgkin's disease and AIDS. Twenty-three new cases and review of literature. Hematol Oncol Clin North Am 1991; 5: 343-56.
12. Ree HJ, Strauchen JA, Khan AA et al. Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells. Cancer 1991; 67: 1614-21.
13. Newcom SR, Ward M, Napoli VM, Kutner M. Treatment of human immunodeficiency virus-associated Hodgkin's disease. Is there a clue regarding the cause of Hodgkin's disease? Cancer 1993; 71: 3138-45.
14. Errante D, Zagonel V, Vaccher E et al. Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival. Ann Oncol 1994; 5 (Suppl 2): S37-72.
15. Tirelli U, Errante D, Vaccher E et al. Hodgkin's disease in 92 patients with HIV infection: The Italian experience. Ann Oncol 1992; 3: S69-72.
16. Errante D, Tirelli U, Gastaldi R et al. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. Cancer 1994; 73: 437-44.
17. Zittoun R, Eghbali H, Audebert A et al. Association d'epirubicine, bleomycine, vinblastine et prednisone (EBVP) avant radiotherapie dans le stades localises de la maladie de Hodgkin. Bull Cancer 1987; 74: 151-7.
18. Lukes RJ, Craver LF, Hall TC et al. Report of the Nomenclature Committee. Cancer Res 1966; 26: 1311.
19. Lukes RJ, Butler JJ, Hicks EB. Natural history of Hodgkin's disease as related to its pathological picture. Cancer 1966; 19: 317-44.
20. Neiman RS. Current problems in the histopathologic diagnosis and classification of Hodgkin's disease. In Sommers SC, Rosen PP (eds): Pathology Annual. Collegeville, PA: Appleton-Century-Crofts 1978: 289-328.
21. Dixon DO, McLaughlin P, Hagemeister FB et al. Reporting outcomes in Hodgkin's disease and lymphoma. J Clin Oncol 1987; 5: 1670-2.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
24. Cox DR. Regression models and life tables. J R Stat Soc Br 1972; 34: 187-202.
25. Kaplan L, Kahn J, Northfelt D et al. Novel combination chemotherapy for Hodgkin's disease in HIV-infected individuals. Proc Am Soc Clin Oncol 1991; 10: 33 (Abstr 7).
26. Levine AM, Cheung T, Tulpule A et al. Preliminary results of AIDS Clinical Trials Group (ACTG) study #149: Phase II trial of ABVD chemotherapy with G-CSF in HIV infected patients with Hodgkin's disease (HD). AIDS 1997; 14: A12 (Abstr 57).
27. Hartmann P, Winkler U, Franzen C et al. Hodgkin's disease in HIV-infected patients BEACOPP is proving to be safe and effective. Leuk Lymph 1998; 29 (Suppl 1): 102 (Abstr P-103).
28. Horning SJ, Rosenberg SA, Hoppe RT. Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update. Ann Oncol 1996; 7 (Suppl 4): 105-8.